US Patent Issued to Academia Sinica on Aug. 11 for "Monocyte-specific aptamers and uses thereof for delivering therapeutic agents to heart" (Taiwanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,716, issued on Aug. 11, was assigned to Academia Sinica (Taipei, Taiwan).

"Monocyte-specific aptamers and uses thereof for delivering therapeutic agents to heart" was invented by Patrick Ch Hsieh (Taipei, Taiwan), Hsien-Ming Lee (Taipei, Taiwan), Keng-Jung Lee (New Taipei City, Taiwan) and Hung-Chih Chen (Changhua County, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Monocyte-specific nucleic acid aptamers and lipid nanoparticles comprising such for use in drug delivery. Also disclosed herein are use of the aptamer-based lipid nanoparticle drug delivery system for treating heart injury."

The patent was filed on May 26, 2021, under Applicati...